Record Information |
---|
Version | 1.0 |
---|
Created at | 2021-06-21 00:38:10 UTC |
---|
Updated at | 2021-06-30 00:18:40 UTC |
---|
NP-MRD ID | NP0043148 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | fluevirosine B |
---|
Provided By | JEOL Database![JEOL Logo](/attributions/jeol_logo.png) |
---|
Description | (1R,2R,8R,9S)-9-[(1S,7S,8S,13R)-3-oxo-7-[(1S,8S,13R)-3-oxo-2-oxa-9-azatetracyclo[6.5.1.0¹,⁵.0⁹,¹³]Tetradeca-4,6-dien-6-yl]-2-oxa-9-azatetracyclo[6.5.1.0¹,⁵.0⁹,¹³]Tetradec-4-en-4-yl]-14-oxa-7-azatetracyclo[6.6.1.0¹,¹¹.0²,⁷]Pentadec-11-en-13-one belongs to the class of organic compounds known as indolizidines. These are polycyclic compounds containing an indolizidine, which is a bicyclic heterocycle containing a saturated six-member ring fused to a saturated five-member ring, one of the bridging atoms being nitrogen. fluevirosine B is found in Flueggea virosa. It was first documented in 2002 (PMID: 29437326). Based on a literature review a significant number of articles have been published on (1R,2R,8R,9S)-9-[(1S,7S,8S,13R)-3-oxo-7-[(1S,8S,13R)-3-oxo-2-oxa-9-azatetracyclo[6.5.1.0¹,⁵.0⁹,¹³]Tetradeca-4,6-dien-6-yl]-2-oxa-9-azatetracyclo[6.5.1.0¹,⁵.0⁹,¹³]Tetradec-4-en-4-yl]-14-oxa-7-azatetracyclo[6.6.1.0¹,¹¹.0²,⁷]Pentadec-11-en-13-one (PMID: 27466641) (PMID: 27253005) (PMID: 26389468) (PMID: 26389426). |
---|
Structure | [H]C1=C2C(=C([H])[C@@]3([H])N4C([H])([H])C([H])([H])C([H])([H])[C@]4([H])[C@]2(OC1=O)C3([H])[H])[C@]1([H])C([H])([H])C2=C(C(=O)O[C@@]22C([H])([H])[C@]1([H])N1C([H])([H])C([H])([H])C([H])([H])[C@]21[H])[C@]1([H])C([H])([H])C2=C([H])C(=O)O[C@]22C([H])([H])[C@@]1([H])N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@]21[H] InChI=1S/C37H41N3O6/c41-31-12-19-11-23(27-17-35(19,44-31)28-5-1-2-8-39(27)28)33-25-14-22(26-18-37(25,46-34(33)43)30-7-4-10-40(26)30)21-13-20-16-36(24(21)15-32(42)45-36)29-6-3-9-38(20)29/h12-13,15,20,22-23,26-30H,1-11,14,16-18H2/t20-,22+,23-,26+,27-,28-,29-,30-,35-,36+,37+/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C37H41N3O6 |
---|
Average Mass | 623.7500 Da |
---|
Monoisotopic Mass | 623.29954 Da |
---|
IUPAC Name | (1R,2R,8R,9S)-9-[(1S,7S,8S,13R)-3-oxo-7-[(1S,8S,13R)-3-oxo-2-oxa-9-azatetracyclo[6.5.1.0^{1,5}.0^{9,13}]tetradeca-4,6-dien-6-yl]-2-oxa-9-azatetracyclo[6.5.1.0^{1,5}.0^{9,13}]tetradec-4-en-4-yl]-14-oxa-7-azatetracyclo[6.6.1.0^{1,11}.0^{2,7}]pentadec-11-en-13-one |
---|
Traditional Name | (1R,2R,8R,9S)-9-[(1S,7S,8S,13R)-3-oxo-7-[(1S,8S,13R)-3-oxo-2-oxa-9-azatetracyclo[6.5.1.0^{1,5}.0^{9,13}]tetradeca-4,6-dien-6-yl]-2-oxa-9-azatetracyclo[6.5.1.0^{1,5}.0^{9,13}]tetradec-4-en-4-yl]-14-oxa-7-azatetracyclo[6.6.1.0^{1,11}.0^{2,7}]pentadec-11-en-13-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H]C1=C2C(=C([H])[C@@]3([H])N4C([H])([H])C([H])([H])C([H])([H])[C@]4([H])[C@]2(OC1=O)C3([H])[H])[C@]1([H])C([H])([H])C2=C(C(=O)O[C@@]22C([H])([H])[C@]1([H])N1C([H])([H])C([H])([H])C([H])([H])[C@]21[H])[C@]1([H])C([H])([H])C2=C([H])C(=O)O[C@]22C([H])([H])[C@@]1([H])N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@]21[H] |
---|
InChI Identifier | InChI=1S/C37H41N3O6/c41-31-12-19-11-23(27-17-35(19,44-31)28-5-1-2-8-39(27)28)33-25-14-22(26-18-37(25,46-34(33)43)30-7-4-10-40(26)30)21-13-20-16-36(24(21)15-32(42)45-36)29-6-3-9-38(20)29/h12-13,15,20,22-23,26-30H,1-11,14,16-18H2/t20-,22+,23-,26+,27-,28-,29-,30-,35-,36+,37+/m1/s1 |
---|
InChI Key | HYWYNBKAWUIHFN-NOLXPYPPSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | Species Name | Source | Reference |
---|
Flueggea virosa | JEOL database | - Zhang, H., et al, Org. Lett.,15 120 (2013)
|
|
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as indolizidines. These are polycyclic compounds containing an indolizidine, which is a bicyclic heterocycle containing a saturated six-member ring fused to a saturated five-member ring, one of the bridging atoms being nitrogen. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indolizidines |
---|
Sub Class | Not Available |
---|
Direct Parent | Indolizidines |
---|
Alternative Parents | |
---|
Substituents | - Indolizidine
- Tricarboxylic acid or derivatives
- Pyrrolizidine
- Azepane
- Azepine
- 2-furanone
- Piperidine
- N-alkylpyrrolidine
- Dihydrofuran
- Pyrrolidine
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Amino acid or derivatives
- Tertiary aliphatic amine
- Tertiary amine
- Lactone
- Carboxylic acid ester
- Azacycle
- Oxacycle
- Carboxylic acid derivative
- Organic nitrogen compound
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Amine
- Aliphatic heteropolycyclic compound
|
---|
Molecular Framework | Aliphatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|